Sentences with phrase «hypoactive sexual»

(Debate) Hypoactive Sexual Desire Disorder: The Importance of Personal Distress.

Dr. Ian Kerner will discuss the latest science - based research informing the treatment of common DSM - 5 sexual issues such as female sexual interest and arousal disorder (FSIAD), male hypoactive sexual desire disorder (HSDD), erectile disorder (ED), premature ejaculation (PE), female orgasmic disorder (FOD), and problematic sexual behaviors such as excessive use of internet pornography.

Sex therapy can help address a number of issues such as: lack of knowledge regarding sexual health; sexual issues related to religion / spirituality, family values, culture, and / or ethnicity; communication barriers related to sexual intimacy; sexual and relationship issues related to an affair and / or differences in sexual pleasure preferences; sexual health related to medical factors; female orgasmic disorder; female sexual interest / arousal disorder; erectile disorder (premature ejaculation); pain experienced during penetration; vaginismus; male hypoactive sexual desire disorder; issues related to sexual orientation and / or gender identity; lacking knowledge or relationship issues related to a sexually transmitted infection and / or safer sex practices; risky sexual behavior related to substance use; sexual issues or relationship issues related to history of sexual abuse; and interest and / or lacking knowledge regarding BDSM, kink, and / or other sexual lifestyles.

Diagnoses include hypoactive sexual desire disorder, sexual aversion disorder, sexual arousal disorder, orgasmic disorder among others.

Medically, a persistently low libido is referred to by doctors as Hypoactive Sexual Desire Disorder; it's thought to affect up to 12 % of women and 5 % of men4, and is most typically associated with married women beyond the first couple of years after their nuptials.

Medically, a persistently low libido is referred to by doctors as Hypoactive Sexual Desire Disorder; it's thought to affect up to 12 % of female libidos and 5 % of male libidos4, and is most typically associated with married women beyond the first couple of years after their nuptials.

Your interest in sex may diminish (low libido or hypoactive sexual desire disorder, HSSD) and you may develop a dry vagina, so that intercourse is irritating (dyspareunia).

Bioidentical hormone replacement therapy is proven to help reduce the symptoms of hypoactive sexual desire, including vaginal dryness, pain during intercourse and diminished sexual interest.

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women..

Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women..

Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.

The drug is intended to treat hypoactive sexual desire disorder (HSDD)-- a persistent lack of libido — in premenopausal women.

Hypoactive sexual desire disorder (HSDD), on the other hand, is a deficiency or absence of sexual fantasies and desire causing marked distress or interpersonal difficulty.

Perhaps men with hypoactive sexual desire disorder couldn't feel desire because their brains were keeping their emotions bottled up.

The other seven suffered from hypoactive sexual desire disorder.

The company said it would instead focus on educating doctors about the drug and the condition it treats, hypoactive sexual desire disorder.

The FDA has twice rejected flibanserin, sometimes touted as a «female Viagra,» first when Boehringer Ingelheim pitched it in 2010 and then again in 2013 after tiny Sprout landed rights to the drug and then mounted its own campaign for an approval for hypoactive sexual desire disorder in premenopausal women.

Many women — some studies estimate this number is as high as one - third of all adult women — have a condition known as female hypoactive sexual desire disorder (HSDD).

The drug treats a condition called hypoactive sexual desire disorder (HSDD), which can cause chronic low desires to have sex in women.

The drug, flibanserin or «Addyi», treats a condition called hypoactive sexual desire disorder (HSDD), which can cause chronic low desires to have sex in women.

But while the U.S. Food and Drug Administration has approved more than two dozen drugs targeting a range of male sexual matters, pharma has turned a cold shoulder to female dysfunction, despite the prevalence of conditions like hypoactive sexual desire disorder, a chronic disinterest in sex estimated to affect 8 to 14 percent of American women ages 20 to 49.